MMI raised $125 million in Series D financing to accelerate commercial growth of its Symani Surgical System and expand access to robotic microsurgery. Existing investor BioStar Capital led the round. New investors S3 Ventures, Angelini Ventures, and an undisclosed strategic corporate investor participated alongside MMI's existing investors.